Pharmacogenomic testing has become increasingly widespread. However, there remains a need to bridge the gap between test results and providers lacking the expertise required to interpret these results. The Indiana Genomics Implementation trial is underway at our institution to examine total healthcare cost and patient outcomes after genotyping in a safety-net healthcare system. As part of the study, trial investigators and clinical pharmacology fellows interpret genotype results, review patient histories and medication lists and evaluate potential drug-drug interactions. We present a case series of patients in whom pharmacogenomic consultations aided providers in appropriately applying pharmacogenomic results within the clinical context. Fo...
It is well known that common variants in specific genes influence drug metabolism and response, but ...
Response to a drug often differs widely among individual patients. This variability is frequently ob...
Thesis (Ph.D.)--University of Washington, 2018The emergence and continual advancement of genomic tec...
Hospital systems increasingly utilize pharmacogenomic testing to inform clinical prescribing. Succes...
Objectives: Implementing new programs to support precision medicine in clinical settings is a comple...
OBJECTIVE: Prior to implementing a trial to evaluate the economic costs and clinical outcomes of pha...
Pharmacogenomics can enhance patient care by enabling treatments tailored to genetic make-up and low...
BACKGROUND: Genome sequencing (GS) of individuals without a medical indication, known as elective GS...
Initial enthusiasm for the potential of pharmacogenomics (PGx) to transform medical practice has bee...
Findings from pharmacogenomics (PGx) studies have the potential to be applied to individualize drug ...
Pharmacogenomics describes interpatient genetic variability in drug responses. Information based on ...
Pharmacogenomics describes interpatient genetic variability in drug responses. Information based on ...
Introduction: Pharmacogenomics (PGx) aims to maximize drug benefits while minimizing risk of toxicit...
Objectives Pharmacogenetic panel-based testing represents a new model for precision medicine. A suf...
The application of pharmacogenomics could meaningfully contribute toward medicines optimization with...
It is well known that common variants in specific genes influence drug metabolism and response, but ...
Response to a drug often differs widely among individual patients. This variability is frequently ob...
Thesis (Ph.D.)--University of Washington, 2018The emergence and continual advancement of genomic tec...
Hospital systems increasingly utilize pharmacogenomic testing to inform clinical prescribing. Succes...
Objectives: Implementing new programs to support precision medicine in clinical settings is a comple...
OBJECTIVE: Prior to implementing a trial to evaluate the economic costs and clinical outcomes of pha...
Pharmacogenomics can enhance patient care by enabling treatments tailored to genetic make-up and low...
BACKGROUND: Genome sequencing (GS) of individuals without a medical indication, known as elective GS...
Initial enthusiasm for the potential of pharmacogenomics (PGx) to transform medical practice has bee...
Findings from pharmacogenomics (PGx) studies have the potential to be applied to individualize drug ...
Pharmacogenomics describes interpatient genetic variability in drug responses. Information based on ...
Pharmacogenomics describes interpatient genetic variability in drug responses. Information based on ...
Introduction: Pharmacogenomics (PGx) aims to maximize drug benefits while minimizing risk of toxicit...
Objectives Pharmacogenetic panel-based testing represents a new model for precision medicine. A suf...
The application of pharmacogenomics could meaningfully contribute toward medicines optimization with...
It is well known that common variants in specific genes influence drug metabolism and response, but ...
Response to a drug often differs widely among individual patients. This variability is frequently ob...
Thesis (Ph.D.)--University of Washington, 2018The emergence and continual advancement of genomic tec...